In addition, autocrine nucleotide release from vascular smooth muscle cells during hyperglycemia has been associated with changes in Ca2+ signaling, activation of transcription factors, and modulation of cell excitability, which seems to be mediated via engagement of one or more purinergic receptors (48, 49). The gene discussed is P2RY2; the disease is Hyperglycemia.